Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

GSK looks to rare diseases research

February 5, 2010 Research and Development GlaxoSmithKline, Orphan

GlaxoSmithKline has launched a new specialist unit to research and develop medicines for rare diseases. The company has identified 5,500 …
News
ABPI

Barker praises OLS model

February 5, 2010 Research and Development, Sales and Marketing ABPI, Blueprint, OLS

The ABPI’s director general spoke to Pharmafocus about the promise of the new Blueprint at its launch in London last …
News
Andrew Witty

GSK confirms job cuts but avoids specifics

February 5, 2010 Research and Development, Sales and Marketing 2009 financials, GlaxoSmithKline

GlaxoSmithKline has sidestepped questions about the internal fall-out from its new plan to slash R&D infrastructure costs. Presenting the company’s …
News
Photo_Miguel_Forte300dpi

Miguel Forte joins TxCell

February 5, 2010 Research and Development TxCell, appointment, research and development

French biotech TxCell has appointed Miguel Forte to fill its newly-created role of chief medical officer. Miguel joins the company …
Appointment

GSK acquires respiratory candidate

February 4, 2010 Research and Development Apeiron, GlaxoSmithKline, respiratory

GlaxoSmithKline has acquired exclusive rights to a biotherapeutic enzyme developed for use against Acute Respiratory Distress Syndrome (ARDS). The move …
News

Lancet retracts MMR research conclusions

February 3, 2010 Research and Development MMR, Sanofi, vaccines

The Lancet, the journal which originally published the controversial research linking the MMR vaccine to autism has issued a full …
News

Digital Pharma: New EMA website previewed

February 3, 2010 Research and Development, Sales and Marketing EMA, branding, digital pharma

The European Medicines Agency is preparing to overhaul its website to make it easier for users to get information. This …
News

FDA to assess Neupogen biosimilar

February 3, 2010 Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …
News

Parexel sees signs of recovery in Q2 figures

February 2, 2010 Research and Development CRO, Parexel

Contract research organisation Parexel International’s second-quarter net profit fell 34% to $3.5 million on restructuring and investment-impairment charges, but still …
News

Job cuts at GlaxoSmithKline and AstraZeneca

February 2, 2010 Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline

Britain’s two biggest pharma companies GlaxoSmithKline and AstraZeneca are poised to make deep job cuts as business models continue to …
News
Lilly laboratory

Lilly signs diabetes deal with Alizé Pharma

February 2, 2010 Research and Development Alize, diabetes, lilly, type II

Lilly has signed a new research and licensing deal with Lyon-based Alizé Pharma to develop Alizé’s AZP-01 programme, focused on …
News

Contract research news in brief

February 2, 2010 Research and Development CRO, PRA, Quintiles

Our round-up of contract research news includes alliances for Quintiles and PRA International, a new CRO serving the Eastern European …
News

Gates’ $10 billion vaccines pledge to cut child mortality

February 1, 2010 Research and Development, Sales and Marketing Gates Foundation, developing world, vaccines

Bill and Melinda Gates are to spend $10 billion over the next 10 years to help research, develop and deliver …
News

Pfizer abandons 100 projects in R&D streamlining

January 28, 2010 Research and Development Pfizer

Pfizer has released details of its new consolidated pipeline following its merger with Wyeth, announcing new priority research areas, and …
News

Cell Medica bolsters senior management

January 28, 2010 Research and Development Cell Medica, appointment, research and development

London-based cellular therapeutics company Cell Medica has made four key appointments. Dr Rainer Knaus joins the company as senior vice …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026